Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer
BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5687-0
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2019
Authors
Publisher
Springer Science and Business Media LLC